From a marketing perspective: where are the future market opportunities in biomaterials?

Clin Mater. 1990;5(2-4):319-24. doi: 10.1016/0267-6605(90)90031-p.


Europe is becoming a center for the development of biomaterials, as the industry becomes increasingly 'globalized'. From a materials perspective, it is clear that all the activity in the biomaterials/medical device industry is in polymers, and bioabsorbable polymers represent a significant market opportunity. To make profits in biomedical polymers, a chemical company must participate in the 'value added chain', whereby the supplier of the chemical (polymer) participates in the profits of the sale to the end-user.

MeSH terms

  • Biocompatible Materials / economics*
  • Clinical Trials as Topic
  • Equipment and Supplies / economics*
  • Europe
  • Forecasting
  • Humans
  • United States


  • Biocompatible Materials